Clinical trial
Effect of Tegaserod on Orocecal Transit in Elderly Chronic Constipation Patients
NCT00348634 · Novartis, Industry · Terminated
Key facts
| NCT number | NCT00348634 |
|---|---|
| Title | Effect of Tegaserod on Orocecal Transit in Elderly Chronic Constipation Patients |
| Official title | The Effects of Tegaserod on Orocecal Transit in Elderly Patients With Chronic Constipation |
| Lead sponsor | Novartis, Industry |
| Collaborators | Temple University University of Michigan |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Chronic Constipation |
| Intervention type | Drug |
| Interventions | Tegaserod |
| Enrollment | 60 |
| Start date | Jul 1, 2006 |
| Primary completion | Apr 1, 2007 |
| Completion | Apr 1, 2007 |
| First posted | Jul 4, 2006 |
| Last update posted | Mar 4, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: